Xiaofeng Zhu
Guiyang, 550025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 27, 2026
ATHENA promotes the assembly of the ATP synthase-associated macromolecular complex and cancer progression.
Journal: Cell death and differentiation
Published: December 28, 2025
m6A modification regulates PLK1 expression and mitosis
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: May 06, 2025
TGMT: A Terminology-Guided Multi-Task Approach for Lung Cancer CT Report Generation.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: March 05, 2025
PD-1IR2 promotes tumor evasion via deregulating CD8+ T cell function.
Journal: Journal for immunotherapy of cancer
Published: February 22, 2025
Posttranscriptional regulation of PD-1 by PRMT5/WDR77 complex shapes T cell effector function and antitumor immunity.
Journal: The Journal of clinical investigation
Published: January 21, 2025
METTL14 Enhances Antitumor Immunity through m6A-Dependent Loss of PD-1.
Journal: Cancer research
Published: January 06, 2025
P5CS represses tumor progression via inhibiting assembly of 48S pre-translation initiation complex.
Journal: Developmental cell
Published: December 17, 2024
DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression.
Journal: Oncogene
Published: December 18, 2023
Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 30, 2023
Last Updated: 09/26/2026